Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Jakarta International Hotels Development Tbk (JIHD) vs Merck Tbk. (MERK) Price & Performance

Jakarta International Hotels Development TbkTrade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Jakarta International Hotels Development Tbk vs Merck Tbk. — how do they compare? Jakarta International Hotels Development Tbk trades at Rp430 (market cap 987.51B, 401.3K 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is the larger of the two by market cap, and Jakarta International Hotels Development Tbk is more actively traded (401.3K versus 37.6K). Which is the better fit depends on your goals.

JIHDMERK
Market Cap
987.51B1.7T
Volume
401.3K37.6K
Lot
4.01K376
Turnover
173.08M144.47M
Average Price
431.293,842.23
Value
173.08M144.47M
Indicative Equilibrium Price
4303,840
Indicative Equilibrium Volume
257

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

JIHD
View details
MERK
View details

About Jakarta International Hotels Development Tbk

PT Jakarta International Hotels and Development Tbk (the Company) was established on November 7, 1967. The Company is the owner of Hotel Borobudur (“the Hotel”) which had been managed and operated by Inter-Continental Hotels (Indonesia) BV (Operator) until December 31, 1998. Starting January 1, 1999, the Hotel has been operated by PT Dharma Harapan Raya 60% of whose shares are owned by the Company.

Read more on JIHD

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK